Diagnostic Pathology · Published 2026-08-01 · DOI 10.1186/s13000-026-01822-7
Kuan Liang, Ziang Jia, Haiwen Lu, Ziling Yan, Haihui Huang, Xia Liu
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Liang, K., Jia, Z., Lu, H., et al. (2026). HER2-low and HER2-ultralow breast cancer in the antibody-drug conjugate era: diagnostic challenges and reporting workflow. Diagnostic Pathology. https://doi.org/10.1186/s13000-026-01822-7